Printer Friendly
The Free Library
14,670,922 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Taisho Pharmaceutical Opens Two New Health Information Websites for Mobile Phones.


Tokyo, Japan, Oct 18, 2005 - (JCNN JCNN Japan Corporate News Network ) - Taisho Pharmaceutical launched two health information websites for mobile phones on October 17.

Naron Fresh C provides useful information on menstrual cramps menstrual cramps Spasmodic dysmenorrhea Gynecology Painful cramps, spasms, lower abdominal discomfort, generally occurring on the first day of the menstrual period; the pain may extend to the low back, thighs, pelvis, and be accompanied by N&V, dizziness,  and the company's proprietary Naron Fresh C painkiller. Preser Ace specializes in hemorrhoids hemorrhoids (hĕm`əroidz) or piles, dilatations of the veins about the anus (external hemorrhoids) or those higher up inside it (internal hemorrhoids).  and offers information on Taisho's unique anti-hemorrhoid series Preser.

The company offers mobile phone users three access methods. Users can take pictures of the two-dimensional bar codes provided at the company's website, send a blank mail to nr@taisho.jp (for Naron Fresh C) and pr@taisho.jp (for Preser Ace), or simply type in the mobile address, http://taisho.jp/pr/.

Source: JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) 
 http://www.japancorp.net

Copyright [c] 2005 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2005 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Oct 19, 2005
Words:119
Previous Article:Guangqi Toyota Engine to Increase Production Capacity.
Next Article:Shimadzu, NEC Jointly Launch Proteomics Data Management Solution.



Related Articles
Taisho Pharmaceutical to Launch OTC-switched Zaditen Nasal Solution.
Taisho Pharmaceutical Begins Marketing Glucocare Powder, Specified Health Food for Inhibiting Rise in Blood Sugar Level.
Sanofi-aventis Japan Acquires Production and Sales Rights of Ancaron Antiarrhythmic Agent from Taisho Pharmaceutical.
Fuji Keizai Publishes Report on Disease Prevention/Health Food Market in Japan.
Astellas Pharma, Taisho Pharmaceutical Both Deny Acquisition of Zepharma by Taisho Pharmaceutical.
Astellas and Toyama Chemical Announce Basic Licensing Agreement on Domestic Marketing and Joint Development of Quinolone Antibiotic T-3811.
Taisho Pharmaceutical Purchases Additional Shares of Yomeishu Seizo.
Taisho Pharmaceutical, Yayoi Foods to Join Hands in Food Business.
Toyama Chemical Files New Drug Application for New-type Quinolone Antibiotic.
Chugai Announces Co-Development and Co-Marketing Agreement with Taisho Pharmaceutical for the Antiresorptive Bisphosphonate R484.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles